SCHEMBL6132028

SCHEMBL6132028

Nc1n[nH]c(-c2ccccc2Cl)c1-c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67
RPS6KA3 P51812 1/20 0.56
AKT2 P31751 1/20 0.51
KMT2A Q03164 1/20 0.51
NPC1 O15118 2/20 0.50
HPGD P15428 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
ALPL P05186 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
NR1H2 P55055 1/20 0.50
NR1H3 Q13133 1/20 0.50
JAK2 O60674 1/20 0.50
JAK1 P23458 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5818294 0.91 MAPK1 (0.54) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL5820038 0.81 MAPK1 (1.00) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132023 0.81 MAPK1 (0.67) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132032 0.81 MAPK1 (0.67) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL8034891 0.80 JAK2 (0.51) MAPK1NPSR1KMT2ANPC1HPGD
SCHEMBL6132076 0.79 MAPK1 (0.80) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132051 0.73 MAPK1 (0.83) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL1225988 0.73 GSK3B (0.44) MAPK1NPSR1AKT2KMT2ANPC1
SCHEMBL6132022 0.72 MAPK1 (0.80) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132080 0.72 MAPK1 (0.80) MAPK1NPSR1RPS6KA3AKT2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP disclosed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP disclosed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO disclosed